These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6046180)

  • 21. Structure of saframycin D, a new dimeric isoquinolinequinone antibiotic.
    Kubo A; Saito N; Kitahara Y; Takahashi K; Yazawa K; Arai T
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):440-2. PubMed ID: 3594668
    [No Abstract]   [Full Text] [Related]  

  • 22. [A new antibiotic with antineoplastic activity: rubidomycin (13,057R.P.). L. Preparation and properties].
    Despois R; Dubost M; Mancy D; Maral R; Ninet L; Pinnert S; Preud'homme J; Charpentie Y; Belloc A; de Chezelles N; Lunel J; Renaut J
    Arzneimittelforschung; 1967 Aug; 17(8):934-9. PubMed ID: 5632066
    [No Abstract]   [Full Text] [Related]  

  • 23. Azinomycins A and B, new antitumor antibiotics. II. Chemical structures.
    Yokoi K; Nagaoka K; Nakashima T
    Chem Pharm Bull (Tokyo); 1986 Nov; 34(11):4554-61. PubMed ID: 3829181
    [No Abstract]   [Full Text] [Related]  

  • 24. Conformational study of antitumor proteins. Neocarzinostatin and a deaminated derivative.
    Maeda H; Ishida N
    Biochim Biophys Acta; 1967 Dec; 147(3):597-9. PubMed ID: 6081860
    [No Abstract]   [Full Text] [Related]  

  • 25. THE ABSOLUTE CONFIGURATION OF SARKOMYCIN.
    SATO Y; NISHIOKA S; YONEMITSU O; BAN Y
    Chem Pharm Bull (Tokyo); 1963 Jul; 11():829-34. PubMed ID: 14075248
    [No Abstract]   [Full Text] [Related]  

  • 26. Direct broth assay for sparsomycin and related nucleoside antitumor antibiotics using reversed-phase high-performance liquid chromatography.
    Poehland BL; Chan JA
    J Chromatogr; 1988 May; 439(2):459-65. PubMed ID: 3403654
    [No Abstract]   [Full Text] [Related]  

  • 27. [Physico-chemical properties of antineoplastic antibiotic rubomycin formed by Act. coeruleorubidus].
    Brazhnikova MG; Konstantinova NV; Pomazhova VA; Zakharov GV
    Antibiotiki; 1966 Sep; 11(9):763-7. PubMed ID: 5996873
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of indirubin by dual wavelength TLC scanner (author's transl)].
    Zhao PP
    Zhong Yao Tong Bao; 1981 Jul; 6(4):28-30. PubMed ID: 6211279
    [No Abstract]   [Full Text] [Related]  

  • 29. Partial sequence of the tyrosine region of neocarzinostatin.
    Glaser CB; Maeda H; Meienhofer J; Niall HD
    Experientia; 1972 Jul; 28(7):772-3. PubMed ID: 4658848
    [No Abstract]   [Full Text] [Related]  

  • 30. Thin-layer chromatography of mycophenolic acid and related compounds.
    Gainer FE; Hussey RL
    J Chromatogr; 1971 Feb; 54(3):446-8. PubMed ID: 5546380
    [No Abstract]   [Full Text] [Related]  

  • 31. The structure of the antibiotic hedamycin I. Chemical, physical and spectral properties.
    Séquin U; Bedford CT; Chung SK; Scott AI
    Helv Chim Acta; 1977 Apr; 60(3):896-906. PubMed ID: 863729
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sibirosamine--now amino sugar from the antibiotic sibiromycin].
    Mezentsev AS; Kuliaeva VV; Rubasheva LM
    Antibiotiki; 1971 Oct; 16(10):867-70. PubMed ID: 5138875
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunodiffusion assay of poricin (NSC-107455).
    Olson BH
    Cancer Chemother Rep; 1972 Dec; 56(6):725-7. PubMed ID: 4634037
    [No Abstract]   [Full Text] [Related]  

  • 34. [Method of determining variamycin using thin-layer chromatography].
    Zhdanovich IuV; Lokshin GB; Petrakushina ZV
    Antibiotiki; 1974 Aug; 19(8):687. PubMed ID: 4455118
    [No Abstract]   [Full Text] [Related]  

  • 35. Desorption chemical ionization mass spectrometry of cosmomycins A, B, C, D and ditrisarubicin B.
    Guglielmetti G; Andriollo N; Cassani G; Vincenti M
    Biomed Environ Mass Spectrom; 1989 May; 18(5):352-4. PubMed ID: 2752189
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of carbohydrate composition of rubomycin B].
    Fedorova GB; Brazhnikova MG; Mezentsev AS; Kshepinskiĭ I
    Antibiotiki; 1970 May; 15(5):403-6. PubMed ID: 5429610
    [No Abstract]   [Full Text] [Related]  

  • 37. [Isolation of a new antibiotic with antitumor activity: rubidomycin (l3,057 R.P.). Identity of rubidomycin and daunomycin].
    Despois R; Dubost M; Mancy D; Maral R; Ninet L; Pinnert S; Preud'homme J; Charpentie Y; Belloc A; Chezelles N DE; Chezelles N; Lunel J; Renaut J
    Pathol Biol; 1967 Oct; 15(19):887-91. PubMed ID: 4869762
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of chemical properties of rubomycin B].
    Brazhnikova MG; Konstantinova NV; Mezentsev AS; Pomazkova VA
    Antibiotiki; 1968 Sep; 13(9):781-5. PubMed ID: 5707350
    [No Abstract]   [Full Text] [Related]  

  • 39. Extra-weak chemiluminescence of drugs. IX. Extra-weak chemiluminescence of neocarzinostatin injection.
    Edo K; Saito K; Kato M; Akiyama-Murai Y; Sato H; Mizugaki M
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4603-7. PubMed ID: 2977573
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluorophotometric enzyme immunoassay of neocarzinostatin using peroxidase as a label.
    Matsuoka K; Maeda M; Tsuji A
    Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1864-8. PubMed ID: 6447549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.